4-nitroquinoline-1-oxide has been researched along with Dysplastic Nevus Syndrome in 2 studies
4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.
Dysplastic Nevus Syndrome: Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirzayans, R | 1 |
| Sabour, M | 1 |
| Paterson, MC | 1 |
| Sato, K | 1 |
| Howell, JN | 1 |
| Greene, MH | 1 |
| Maher, VM | 1 |
| McCormick, JJ | 1 |
2 other studies available for 4-nitroquinoline-1-oxide and Dysplastic Nevus Syndrome
| Article | Year |
|---|---|
Bioreduction of 4-nitroquinoline 1-oxide in dysplastic nevus syndrome fibroblasts.
Topics: 4-Nitroquinoline-1-oxide; Biotransformation; Cell Line; DNA Damage; Dysplastic Nevus Syndrome; Human | 1989 |
Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
Topics: 4-Nitroquinoline-1-oxide; Cell Line; Cell Survival; Dysplastic Nevus Syndrome; Humans; Male; Melanom | 1988 |